Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Revisão |
| Hizkuntza: | ingelesa |
| Argitaratua: |
2020
|
| Sarrera elektronikoa: | https://doi.org/10.1080/14737159.2020.1768849 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|